Literature DB >> 20091050

Tumor expression of integrin-linked kinase (ILK) correlates with the expression of the E-cadherin repressor snail: an immunohistochemical study in ductal pancreatic adenocarcinoma.

David F Schaeffer1, Kiran Assi, Katie Chan, Andrzej K Buczkowski, Stephen W Chung, Charles H Scudamore, Alan Weiss, Bill Salh, David A Owen.   

Abstract

Integrin-linked kinase (ILK) is a key molecule involved in mediating several biological functions including cell-matrix interactions, angiogenesis, and invasion, as well as playing a role in epithelial to mesenchymal transition (EMT) in cancer cells. In ductal pancreatic adenocarcinoma, increased expression of ILK has been linked to tumor prognosis and correlated with increased chemoresistance to drugs, such as gemcitabine. However, the precise relationship between ILK, Snail, E-cadherin, and N-cadherin expression on the stepwise development of pancreatic cancer is unknown. Hence, the purpose of this work was to investigate levels of expression of ILK, Snail, and the cadherins in pancreatic intraepithelial neoplasia (PanIN), and cancer. Resection specimens of 25 randomly selected patients, who underwent a pyloric preserving pancreatoduodenectomy for ductal pancreatic adenocarcinoma, were utilized for this study. Formalin-fixed paraffin embedded pancreatic tissue was immunostained for ILK, E-cadherin, N-cadherin, and Snail by standard techniques. The extent of staining positivity was scored and the results correlated with clinicopathological parameters. In 23 of 25 cases, ILK expression showed extensive positivity (>50%), while two cases did not demonstrate any ILK staining. PanIN grades 1 (n = 16), 2 (n = 11), and 3 (n = 19) lesions demonstrated only focal positivity (<10%) for ILK. E-cadherin showed a reciprocal staining pattern to ILK in 21 of 25 cases, with only focal expression of the marker in pancreatic adenocarcinoma. Interestingly, 15 of 19 PanIN-3 lesions expressed extensive E-cadherin staining. N-cadherin, however, was moderately expressed in the majority of cases (n = 18). Snail expression (n = 22) correlated with ILK expression in ductal pancreatic adenocarcinoma (rho = 0.8168, p = 0.02), but only minimal Snail staining activity was detected in PanIN lesions. The increase in expression of the E-cadherin repressor Snail, as well as the related increase in the ILK expression, may point towards an ILK-mediated induction, opening possible avenues for targeted drug therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20091050     DOI: 10.1007/s00428-009-0866-z

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  32 in total

1.  Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells.

Authors:  C Tan; P Costello; J Sanghera; D Dominguez; J Baulida; A G de Herreros; S Dedhar
Journal:  Oncogene       Date:  2001-01-04       Impact factor: 9.867

Review 2.  Adjuvant treatment for resectable pancreatic cancer.

Authors:  Yu Jo Chua; David Cunningham
Journal:  J Clin Oncol       Date:  2005-07-10       Impact factor: 44.544

Review 3.  Integrin-linked kinase: a cancer therapeutic target unique among its ILK.

Authors:  Gregory Hannigan; Armelle A Troussard; Shoukat Dedhar
Journal:  Nat Rev Cancer       Date:  2005-01       Impact factor: 60.716

4.  Integrin-linked kinase activity is associated with interleukin-1 alpha-induced progressive behavior of pancreatic cancer and poor patient survival.

Authors:  H Sawai; Y Okada; H Funahashi; Y Matsuo; H Takahashi; H Takeyama; T Manabe
Journal:  Oncogene       Date:  2006-01-16       Impact factor: 9.867

5.  Integrin-linked kinase activity regulates Rac- and Cdc42-mediated actin cytoskeleton reorganization via alpha-PIX.

Authors:  Nolan R Filipenko; Sarah Attwell; Calvin Roskelley; Shoukat Dedhar
Journal:  Oncogene       Date:  2005-09-01       Impact factor: 9.867

6.  Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion.

Authors:  Vasily Vasko; Allan V Espinosa; William Scouten; Huiling He; Herbert Auer; Sandya Liyanarachchi; Alexander Larin; Victoria Savchenko; Gary L Francis; Albert de la Chapelle; Motoyasu Saji; Matthew D Ringel
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-12       Impact factor: 11.205

Review 7.  Epithelial-mesenchymal transitions in cancer progression.

Authors:  C Birchmeier; W Birchmeier; B Brand-Saberi
Journal:  Acta Anat (Basel)       Date:  1996

8.  Expression and prognostic roles of integrins and interleukin-1 receptor type I in patients with ductal adenocarcinoma of the pancreas.

Authors:  Hirozumi Sawai; Hitoshi Funahashi; Yoichi Matsuo; Minoru Yamamoto; Yuji Okada; Tetsushi Hayakawa; Tadao Manabe
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

9.  Regulation of tumor angiogenesis by integrin-linked kinase (ILK).

Authors:  Clara Tan; Severine Cruet-Hennequart; Armelle Troussard; Ladan Fazli; Penny Costello; Kym Sutton; Jeff Wheeler; Martin Gleave; Jasbinder Sanghera; Shoukat Dedhar
Journal:  Cancer Cell       Date:  2004-01       Impact factor: 31.743

10.  Integrin-linked kinase regulates cell proliferation and tumour growth in murine colitis-associated carcinogenesis.

Authors:  K Assi; J Mills; D Owen; C Ong; R St Arnaud; S Dedhar; B Salh
Journal:  Gut       Date:  2008-03-07       Impact factor: 23.059

View more
  15 in total

1.  Identification and characterization of a novel integrin-linked kinase inhibitor.

Authors:  Su-Lin Lee; En-Chi Hsu; Chih-Chien Chou; Hsiao-Ching Chuang; Li-Yuan Bai; Samuel K Kulp; Ching-Shih Chen
Journal:  J Med Chem       Date:  2011-08-24       Impact factor: 7.446

2.  Integrin-linked kinase (ILK) expression correlates with tumor severity in clear cell renal carcinoma.

Authors:  Míriam de Fátima Brasil Engelman; Rogério Mendes Grande; Marcelo Andery Naves; Marcello Fabiano de Franco; Vicente de Paulo Castro Teixeira
Journal:  Pathol Oncol Res       Date:  2012-07-20       Impact factor: 3.201

3.  Targeting integrin-linked kinase to suppress oncogenic KRAS signaling in pancreatic cancer.

Authors:  Po-Chen Chu; Samuel K Kulp; Tanios Bekaii-Saab; Ching-Shih Chen
Journal:  Small GTPases       Date:  2016-12-09

4.  Regulation of oncogenic KRAS signaling via a novel KRAS-integrin-linked kinase-hnRNPA1 regulatory loop in human pancreatic cancer cells.

Authors:  P-C Chu; M-C Yang; S K Kulp; S B Salunke; L E Himmel; C-S Fang; A M Jadhav; Y-S Shan; C-T Lee; M-D Lai; L A Shirley; T Bekaii-Saab; C-S Chen
Journal:  Oncogene       Date:  2015-11-30       Impact factor: 9.867

5.  Nestin regulates epithelial-mesenchymal transition marker expression in pancreatic ductal adenocarcinoma cell lines.

Authors:  Masahito Hagio; Yoko Matsuda; Taeko Suzuki; Toshiyuki Ishiwata
Journal:  Mol Clin Oncol       Date:  2012-06-08

6.  Requirement of epithelial integrin-linked kinase for facilitation of Citrobacter rodentium-induced colitis.

Authors:  Kiran Assi; Kirk Bergstrom; Bruce Vallance; David Owen; Baljinder Salh
Journal:  BMC Gastroenterol       Date:  2013-09-11       Impact factor: 3.067

7.  Functional Role of mTORC2 versus Integrin-Linked Kinase in Mediating Ser473-Akt Phosphorylation in PTEN-Negative Prostate and Breast Cancer Cell Lines.

Authors:  Su-Lin Lee; Chih-Chien Chou; Hsiao-Ching Chuang; En-Chi Hsu; Po-Chen Chiu; Samuel K Kulp; John C Byrd; Ching-Shih Chen
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

8.  Epithelial-mesenchymal transition in pancreatic carcinoma.

Authors:  Harald J Maier; Thomas Wirth; Hartmut Beug
Journal:  Cancers (Basel)       Date:  2010-12-09       Impact factor: 6.639

9.  Metachronous pancreatic cancer originating from disseminated founder pancreatic intraductal neoplasias (PanINs).

Authors:  Koji Imai; Hidenori Karasaki; Yusuke Ono; Junpei Sasajima; Shin-Ichi Chiba; Hiroshi Funakoshi; Miho Muraki; Hideki Hanaoka; Takahisa Furukawa; Hiroyuki Furukawa; Toru Kono; Kazuo Nagashima; Yusuke Mizukami
Journal:  J Pathol Clin Res       Date:  2015-02-02

10.  Integrin-linked kinase regulates cadherin switch in bladder cancer.

Authors:  Dorota Gil; Dorota Ciołczyk-Wierzbicka; Joanna Dulińska-Litewka; Piotr Laidler
Journal:  Tumour Biol       Date:  2016-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.